 |
市場調查報告書
商品編碼
1424393
全球解毒劑市場：按類型、給藥途徑、最終用戶、地區Global Antidote Market, By Type, By Route of Administration, By End User, By Geography |
||||||
全球解毒劑市場規模預計將從2023年的27億美元增加至2030年的45.8億美元，預測期內複合年成長率為7.8%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2022年 | 2023/2024年市場規模 | 27億美元 |
| 實際資料 | 2017年至2021年 | 預測期 | 2023-2030 |
| 2023/2024-2030/2031預測期複合年成長率 | 7.80% | 2030/2031價值預測 | 45.8億美元 |
由於世界各地中毒案例的增加，全球解毒劑市場在過去幾年中一直穩步成長。中毒可能是由於攝入有毒化學物質、藥物或其他有害物質而意外或故意發生的。解毒劑是用於抵消毒物、毒素或某些醫療狀況的影響的藥物製劑。解毒劑透過抑制毒物在體內發揮毒性的機制發揮作用。隨著現代環境污染和藥物濫用的加劇，針對有毒物質的有效抗蛇毒血清治療的需求不斷增加。市面上提供了多種常見中毒病例的解毒劑，包括鴉片類藥物、有機磷酸鹽、甲醇、Chloroquine和其他毒物。領先公司致力於開發具有更好功效和安全性的新穎配方，以滿足未滿足的需求。
市場動態：
全球意外和故意中毒事件的增加是解毒劑市場的主要驅動力。環境污染和工業廢棄物的增加同時也增加了有毒化學物質的暴露。藥物濫用疾病的顯著增加也增加了因處方藥和娛樂性藥物過量攝取而上癮的風險。然而，解毒劑生產成本高、部分產品保存期限短以及偏遠地區無法取得，在一定程度上限制了更廣泛的市場吸收。同時，先進替代治療方法的研發進展以及新興國家醫療保健覆蓋範圍的擴大預計將創造新的機會。針對特定毒素和生物恐怖主義製劑的解毒劑的開發也具有廣闊的前景。此外，需要使用解毒劑的醫療問題包括肺炎的預防性治療、戒菸輔助、弓形蟲病的治療、對抗鴉片類藥物過量攝取、逆轉鴉片類藥物引起的鎮靜、解決拔毛癖和逆轉鎮靜。這種情況的不斷增加也推動了市場的發展擴張。
本研究的主要特點
- 本報告對全球解毒劑市場進行了詳細分析，並提出了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
- 它還闡明了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
- 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
- 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球解毒劑市場的主要企業。
- 該報告的見解使行銷人員和經營團隊負責人就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 全球解毒劑市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
- 相關人員可以透過分析全球解毒劑市場時所使用的各種策略矩陣來促進他們的決策。
目錄
第1章 研究目的與前提
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規及趨勢分析
- 市場動態
- 影響分析
- 監管場景
- 服務交付組合
- PEST分析
- 波特的分析
- 併購場景
第4章全球解毒劑市場－冠狀病毒（COVID-19）大流行的影響
- 新型冠狀病毒感染疾病（COVID-19）的流行病學
- 供需面分析
- 經濟影響
第5章全球解毒劑市場，按類型，2018-2030
- 介紹
- 化學解毒劑
- 物理解毒劑
- 藥理解毒劑
第6章 全球解毒劑市場，依給藥途徑，2018-2030
- 介紹
- 口服
- 局部的
- 注射
- 其他
第7章 全球解毒劑市場，按最終用戶分類，2018-2030 年
- 介紹
- 醫院
- 專科診所
- 其他
第8章2018-2030年全球解毒劑市場（按地區）
- 介紹
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 歐洲其他地區
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- 東南亞國協
- 其他亞太地區
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中部非洲
- 南非
第9章 競爭形勢
- Reddy's Laboratories Ltd
- Viatris Inc.
- Fresenius Kabi AG
- Zydus Lifesciences Ltd.
- Endo International plc
- Novartis AG
- Baxter International, Inc.
- Emergent BioSolutions Inc.
- Pfizer Inc.
- Hikma Pharmaceuticals PLC
- Incepta Pharma
- VINS Bioproducts Ltd
- Bharat Serums and Vaccines Limited
- CSL Limited
- Mediclone Biotech
- Shanghai Serum Bio-technology Co., LTD.
- Haffkine Bio-pharmaceutical Corporation Ltd.
- Premium Serums
第10章
- 調查方法
- 關於出版商
The global antidote market size is expected to reach US$ 4.58 Bn by 2030, from US$ 2.70 Bn in 2023, exhibiting a CAGR of 7.8% during the forecast period.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023/2024: | US$ 2.70 Bn |
| Historical Data for: | 2017 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023/2024 to 2030/2031 CAGR: | 7.80% | 2030/2031 Value Projection: | US$ 4.58 Bn |
The global antidote market has been witnessing steady growth over the past few years owing to the growing incidence of poisoning cases across the world. Poisoning can occur accidentally or intentionally through the consumption of toxic chemicals, drugs, or other harmful substances. Antidotes are pharmaceutical preparations administered to counteract the effects of poisons, toxins, or certain disease states. They work by blocking the mechanisms through which poisons produce their toxic effects in the body. With rising environmental pollution and drug abuse in modern times, the need for effective antidotal treatments for poisoning is increasing continuously. The market offers a wide range of antidotes for common poisoning cases involving opioids, organophosphates, methanol, chloroquine, and other toxic agents. Leading players are focusing on developing novel formulations with better efficacy and safety profiles to cater to unmet needs.
Market Dynamics:
The increasing incidence of accidental and intentional poisoning worldwide is a major driver for the antidote market. Growing environmental pollution and industrial waste have simultaneously increased exposure to toxic chemicals. A significant rise in substance abuse disorders has also heightened poisoning risks from overdoses of prescription medications and recreational drugs. However, high costs associated with antidote production, the short shelf life of some products, and the lack of availability in remote regions restrict broader market uptake to some extent. On the other hand, ongoing research and development into advanced therapeutic alternatives and expanding healthcare access in emerging nations are expected to create new opportunities. The development of antidotes for specialty toxins and bioterrorism agents also holds promising prospects. For instance, in March 2022, according to a report published by the National Center for Biotechnology Information, approximately 121,729 fatalities were reported due to drug overdose in 2021, in the U.S. Additionally, the rising occurrence of medical issues that require the use of antidotes, including preventative treatment for pneumonia, aid in quitting smoking, treatment for toxoplasmosis, countering opioid overdose, reversing opioid-induced sedation, addressing trichotillomania, and reversing sedation, is propelling market expansion.
Key features of the study:
- This report provides in-depth analysis of the global antidote market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global antidote market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Dr. Reddy's Laboratories Ltd Viatris Inc., Fresenius Kabi AG, Zydus Lifesciences Ltd., Endo International plc, Novartis AG, Baxter International, Inc., Emergent BioSolutions Inc., Pfizer Inc., Hikma Pharmaceuticals PLC, Incepta Pharma, VINS Bioproducts Ltd Bharat Serums and Vaccines Limited, CSL Limited, Mediclone Biotech, Shanghai Serum Bio-technology Co., LTD., Haffkine Bio-pharmaceutical Corporation Ltd. and Premium Serums
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global antidote market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antidote market
Detailed Segmentation:
- Global Antidote Market, By Type
- Chemical Antidote
- Physical Antidote
- Pharmacological Antidote
- Global Antidote Market, By Route of Administration
- Oral
- Topical
- Injectable
- Others
- Global Antidote Market, By End User
- Hospitals
- Speciality Clinics
- Others
- Global Antidote Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Global Antidote Market, Key Players
- Reddy's Laboratories Ltd
- Viatris Inc.
- Fresenius Kabi AG
- Zydus Lifesciences Ltd.
- Endo International plc
- Novartis AG
- Baxter International, Inc.
- Emergent BioSolutions Inc.
- Pfizer Inc.
- Hikma Pharmaceuticals PLC
- Incepta Pharma
- VINS Bioproducts Ltd
- Bharat Serums and Vaccines Limited
- CSL Limited
- Mediclone Biotech
- Shanghai Serum Bio-technology Co., LTD.
- Haffkine Bio-pharmaceutical Corporation Ltd.
- Premium Serums
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Antidote Market, By Type
- Global Antidote Market, By Route of Administration
- Global Antidote Market, By End User
- Global Antidote Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rise in cases of accidental poisoning
- Stringent regulations for approval of antidotes
- Increasing demand for generic antidotes
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Service offering Portfolio
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Antidote Market- Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Antidote Market, By Type, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Chemical Antidote
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Physical Antidote
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Pharmacological Antidote
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
6. Global Antidote Market, By Route of Administration, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
7. Global Antidote Market, By End User, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Speciality Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
8. Global Antidote Market, By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Reddy's Laboratories Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Fresenius Kabi AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Zydus Lifesciences Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Endo International plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Strategies
- Baxter International, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Emergent BioSolutions Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Incepta Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- VINS Bioproducts Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bharat Serums and Vaccines Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mediclone Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Shanghai Serum Bio-technology Co., LTD.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Haffkine Bio-pharmaceutical Corporation Ltd.
- Premium Serums
- Analyst Views
10. Section
- Research Methodology
- About us
解毒劑的全球市場:成長，未來展望，競爭分析，2024～2032年
解毒劑市場 - 按類型、給藥途徑、應用、最終用途 - 全球預測
解毒劑市場、份額、規模、趨勢、行業分析報告：按類型、給藥途徑、分銷管道、最終用途、地區、細分市場預測，2024-2032